Search research articles
Contact Us
Filters
Showing results (41-50 of 86) with videos related to
Page
of 9
Sort By:
Leukemia & Lymphoma
|
February 13, 2004
Induction of complete remission using single agent clofarabine in a patient with primary refractory acute myeloblaste leukemia
Dan Douer, Kristy Watkins, Alexandra M Levine, et al.
Hematological Oncology
|
November 12, 2021
Immunophenotype of acute lymphoblastic leukemia in minorities- analysis from the SEER database
Elisa Quiroz, Aparajit Ram Venkateswaran, Rebecca Nelson, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 1, 2010
Treatment of patients with acute promyelocytic leukemia: a consensus statement on risk-adapted approaches to therapy
Martin Tallman, Dan Douer, Steven Gore, et al.
Blood
|
November 30, 2006
Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia
Dan Douer, Henry Yampolsky, Lewis J Cohen, et al.
Open Medicine (Warsaw, Poland)
|
July 22, 2017
Impact of Chromosomal Rearrangement upon DNA Methylation Patterns in Leukemia
Hyang-Min Byun, Shahrooz Eshaghian, Dan Douer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2006
Phase II multicenter study of arsenic trioxide in patients with myelodysplastic syndromes
Gary J Schiller, James Slack, John D Hainsworth, et al.
Epigenetics
|
September 24, 2010
A phase I biological study of azacitidine (Vidaza™) to determine the optimal dose to inhibit DNA methylation
Ilan Bernstein, Hyang-Min Byun, Ann Mohrbacher, et al.
American Journal of Hematology
|
October 11, 2025
Optimizing Asparaginase Treatment for Adolescent and Young Adult (AYA) Patients With Acute Lymphoblastic Leukemia: US Consensus Panel Recommendations
Ibrahim Aldoss, Amir Ali, Ryan D Cassaday, et al.
British Journal of Haematology
|
August 6, 2003
Acute promyelocytic leukaemia in patients originating in Latin America is associated with an increased frequency of the bcr1 subtype of the PML/RARalpha fusion gene
Dan Douer, Sergio Santillana, Laleh Ramezani, et al.
Leukemia Research
|
February 7, 2018
Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent doses
Patrick W Burke, Ibrahim Aldoss, Matthew A Lunning, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 86) with videos related to
Sort By:
Page
of 9
Leukemia & Lymphoma
|
February 13, 2004
Induction of complete remission using single agent clofarabine in a patient with primary refractory acute myeloblaste leukemia
Dan Douer, Kristy Watkins, Alexandra M Levine, et al.
Hematological Oncology
|
November 12, 2021
Immunophenotype of acute lymphoblastic leukemia in minorities- analysis from the SEER database
Elisa Quiroz, Aparajit Ram Venkateswaran, Rebecca Nelson, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 1, 2010
Treatment of patients with acute promyelocytic leukemia: a consensus statement on risk-adapted approaches to therapy
Martin Tallman, Dan Douer, Steven Gore, et al.
Blood
|
November 30, 2006
Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia
Dan Douer, Henry Yampolsky, Lewis J Cohen, et al.
Open Medicine (Warsaw, Poland)
|
July 22, 2017
Impact of Chromosomal Rearrangement upon DNA Methylation Patterns in Leukemia
Hyang-Min Byun, Shahrooz Eshaghian, Dan Douer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2006
Phase II multicenter study of arsenic trioxide in patients with myelodysplastic syndromes
Gary J Schiller, James Slack, John D Hainsworth, et al.
Epigenetics
|
September 24, 2010
A phase I biological study of azacitidine (Vidaza™) to determine the optimal dose to inhibit DNA methylation
Ilan Bernstein, Hyang-Min Byun, Ann Mohrbacher, et al.
American Journal of Hematology
|
October 11, 2025
Optimizing Asparaginase Treatment for Adolescent and Young Adult (AYA) Patients With Acute Lymphoblastic Leukemia: US Consensus Panel Recommendations
Ibrahim Aldoss, Amir Ali, Ryan D Cassaday, et al.
British Journal of Haematology
|
August 6, 2003
Acute promyelocytic leukaemia in patients originating in Latin America is associated with an increased frequency of the bcr1 subtype of the PML/RARalpha fusion gene
Dan Douer, Sergio Santillana, Laleh Ramezani, et al.
Leukemia Research
|
February 7, 2018
Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent doses
Patrick W Burke, Ibrahim Aldoss, Matthew A Lunning, et al.
Page
of 9